Skip to main content
. 2018 Jun 4;49(4):617–627. doi: 10.1017/S0033291718001307

Table 4.

Distribution of characteristics across identified classes in the sample of subjects with current psychopathology

Lean (N = 311) Average (N = 910) Overweight (N = 239) p*
Demographics and covariates
Age, mean (s.d.) 40.5 (12.23) 42.1 (12.59) 43.2 (11.49) 0.033
Sex, % female (N) 66.9 (208) 66.2 (602) 66.1 (158) 0.971
Metabolic syndrome, % (n) (medication adjusted) 2.7 (8) 18.8 (167) 65.3 (154) <0.001a,b,c
Number of chronic diseases <0.001b,c
 0, N (%) 135 (43.4) 381 (41.9) 69 (28.9)
 1, N (%) 102 (32.8) 301 (33.1) 74 (31.0)
 2, N (%) 47 (15.1) 143 (15.7) 55 (23.0)
 3 + , N (%) 27 (8.7) 85 (9.3) 41 (17.1)
Lifestyle factors
Smokers, N (%) 48.2 (150) 39.9 (363) 43.1 (103) 0.035
Alcohol abuse (audit), mean (s.d.) 5.8 (6.34) 4.7 (4.97) 3.7 (5.11) <0.001a,b,c
Medication use
Psychotropics, % (N) 67.2 (209) 71.5 (651) 77.4 (182) 0.018b,c
SSRI, % (N) 22.5 (70) 26.3 (241) 28.4 (68) 0.457
TCA, % (N) 0.6 (2) 4.1 (37) 8.4 (20) <0.001b
Benzodiazepine, % (N) 22.2 (69) 24.0 (218) 28.0 (66) 0.410
Current diagnosis (last month) 0.300
Depression only, % (N) 24.8 (77) 24.1 (219) 26.4 (63)
Anxiety only, % (N) 37.0 (115) 37.1 (338) 29.7 (71)
Comorbidity, % (N) 38.3 (119) 38.5 (353) 43.9 (105)
Age of onset, mean (s.d.) 18.1 (11.15) 21.6 (12.77) 22.64 (12.87) 0.000a,b
Number of depression diagnoses 0.192
1, % (N) 46.6 (145) 48.6 (442) 50.2 (120)
2, % (N) 16.4 (51) 14.3 (130) 20.1 (48)
Number of anxiety diagnoses 0.425
1, % (N) 47.3 (147) 48.9 (445) 42.3 (101)
2, % (N) 19.0 (59) 20.4 (186) 24.3 (58)
3, % (N) 9.0 (28) 6.6 (60) 7.2 (17)
Months with depression symptoms, mean (s.d.) 21.4 (16.33) 20.3 (14.19) 21.7 (17.10) 0.206
Months with anxiety symptoms, mean (s.d.) 26.8 (19.46) 26.7 (19.57) 24.5 (18.29) 0.544
Months with avoidance symptoms, mean (s.d.) 30.3 (21.01) 30.6 (22.55) 26.6 (22.12) 0.192
Internalizing diagnoses
MDD, % (N) 53.7 (166) 53.3 (485) 63.2 (151) 0.020b,c
Minor Depression, % (N) 6.4 (20) 5.9 (54) 4.2 (10) 0.496
Dysthymia, % (N) 19.6 (61) 17.9 (163) 23.0 (55) 0.197
Social phobia, % (N) 42.8 (133) 36.8 (335) 35.6 (85) 0.126
Panic W. Agoraphobia, % (N) 21.9 (78) 25.3 (230) 23.8 (57) 0.473
Panic W.O. Agoraphobia, % (N) 10.6 (33) 10.4 (95) 11.7 (28) 0.850
Agoraphobia, % (N) 9.6 (30) 10.1 (92) 13.0 (31) 0.378
GAD, % (N) 27.3 (85) 26.9 (245) 28.0 (67) 0.941
Depression severitiy (IDS), mean (s.d.) 29.70 (11.64) 30.01 (12.11) 34.39 (12.95) <0.001b,c
Anxiety Severity (BAI), Mean (s.d.) 16.64 (9.98) 18.02 (10.48) 20.99 (12.57) <0.001b
Number of MDD episodes, mean (s.d.) 4.9 (8.31) 5.4 (11.84) 4.7 (8.46) 0.333
IDS subscale
Atypical, % (N) 15.0 (45) 19.6 (175) 28.4 (66) <0.001b
Melancholic, % (N) 14.3 (43) 10.5 (94) 16.0 (37) 0.035
Bai subscale, mean (s.d.)
Somatic 9.5 (6.73) 10.6 (7.03) 13.0 (8.26) <0.001b,c
Subjective 7.1 (4.37) 7.4 (4.46) 8.0 (5.39) 0.395

AUDIT, alcohol use disorder identification test; BAI, Beck Anxiety Inventory; BMI, body mass index; CIDI, Composite Interview Diagnostic Instrument; GAD, generalized anxiety disorder; IDS, Inventory of Depressive Symptomatology; MDD, major depression, NA, not applicable; SSRI, selective serotonin reuptake inhibitors; TCA, tricyclic antidepressants.

*Based on ANOVA for continuous variables (post-hoc = Tukey), Kruskal–Wallis tests for non-normally distributed variables (post-hoc = Dunn test) and chi-square test for categorical variables.

Significant differences by class (at α < 0.05 corrected using the False Discovery Rate controlling method):

a

‘lean’ v. ‘average’ class.

b

‘lean’ v. ‘overweight’ class.

c

‘average’ v. ‘overweight’ class.